This document references 23 sources that relate to epidemiology, etiology, and prognosis of acute and chronic pancreatitis. Key points discussed across the sources include: trends in global incidence and mortality of pancreatic diseases; risk factors such as alcohol consumption, hypertriglyceridemia, hyperparathyroidism, and certain medications; progression from acute to chronic pancreatitis; and genetic factors like blood type B and fucosyltransferase 2 non-secretor status that may increase risk. The document also references revisions made in 2012 to the Atlanta classification system for acute pancreatitis.

28. 1. Lowenfels AB, et al. The changing character of acute pancreatitis: Epidemiology, etiology, and prognosis. Curr Gastroenterol Rep 2009; 11: 97–103. [https://link.springer.com/article/10.1007%2Fs11894-009-0016-4]
2. Xiao AY, et al. Global incidence and mortality of pancreatic diseases: a systematic review, meta-analysis, and meta-regression of population-based cohort studies. Lancet Gastroenterol Hepatol 2016; 1: 45–55 [https://www.thelancet.com/journals/langas/article/PIIS2468-
1253(16)30004-8/fulltext]
3. Petrov MS and Yadav D. Global epidemiology and holistic prevention of pancreatitis. Nat Rev Gastroenterol Hepatol 2019; 163: 175–184. [https://www.nature.com/articles/s41575-018-0087-5]
4. Healthcare Cost and Utilization Project (HCUP). National (Nationwide) Inpatient Sample (NIS). [https://www.hcup-us.ahrq.gov/db/nation/nis/nisdbdocumentation.jsp]
5. Nøjgaard C, et al. Progression from acute to chronic pancreatitis: prognostic factors, mortality, and natural course. Pancreas 2011; 40: 1195–1200. [https://journals.lww.com/pancreasjournal/fulltext/10.1097/MPA.0b013e318221f569]
6. Ammann R, et al. Acute (nonprogressive) alcoholic pancreatitis: prospective longitudinal study of 144 patients with recurrent alcoholic pancreatitis. Pancreas 1986; 1: 195–203.
[https://journals.lww.com/pancreasjournal/pages/articleviewer.aspx?year=1986&issue=05000&article=00001&type=abstract]
7. Lankisch PG, et al. Natural history of acute pancreatitis: a long-term population-based study. Am J Gastroenterol 2009; 104: 2797–805. [https://journals.lww.com/ajg/Abstract/2009/11000/Natural_History_of_Acute_Pancreatitis__A_Long_Term.26.aspx]
8. Lankisch PG, et al. Which etiology causes the most severe acute pancreatitis? Int J Pancreatol 1999; 26: 55–57. [https://link.springer.com/article/10.1007%2FBF02781731]
9. Mikolasevic I, et al. Metabolic syndrome and acute pancreatitis. Eur J Intern Med 2016; 32: 79–83. [https://www.ejinme.com/article/S0953-6205(16)30073-5/fulltext]
10. Toskes PP. Hyperlipidemic pancreatitis. Gastroenterol Clin North Am 1990; 19: 783–791. [https://pubmed.ncbi.nlm.nih.gov/2269517/]
11. Bess MA, et al. Hyperparathyroidism and pancreatitis. Chance or a causal association? JAMA 1980; 243: 246–247. [https://jamanetwork.com/journals/jama/article-abstract/368364]
12. Russel CF and Edis AJ. Surgery for primary hyperparathyroidism: experience with 500 consecutive cases and evaluation of the role of surgery in the asymptomatic patient Br J Surg 1982; 69: 244–247.
[https://bjssjournals.onlinelibrary.wiley.com/doi/abs/10.1002/bjs.1800690503]
13. Foley TP, et al. Familial benign hypercalcemia. J Pediatr 1972; 81: 1060–1067. [https://www.jpeds.com/article/S0022-3476(72)80232-4/pdf]
14. Felderbauer P, et al. Mutations in the calcium-sensing receptor: a new genetic risk factor for chronic pancreatitis? Scand J Gastroenterol 2006; 41: 343–348. [https://www.tandfonline.com/doi/full/10.1080/00365520510024214]
15. Bahada SK et al. Chronic pancreatitis in primary hyperparathyroidism: comparison with alcoholic and idiopathic chronic pancreatitis. J Gastroenterol Hepatol 2008; 23: 959–964. [https://onlinelibrary.wiley.com/doi/full/10.1111/j.1440-1746.2007.05050.x]
16. Bai HX, The Association of Primary Hyperparathyroidism With Pancreatitis . J Clin Gastroenterol 2012; 46: 656–661. [https://journals.lww.com/jcge/Abstract/2012/09000/The_Association_of_Primary_Hyperparathyroidism.9.aspx]
17. Pedersen SB, et al. Nonfasting mild-to-moderate hypertriglyceridemia and risk of acute pancreatitis. JAMA Intern Med 2016; 176: 1834–1842. [https://jamanetwork.com/journals/jamainternalmedicine/fullarticle/2580722]
18. Nitsche C, Drug-induced pancreatitis. Curr Gastroenterol Rep 2012; 14: 131–138. [https://link.springer.com/article/10.1007/s11894-012-0245-9]
19. Karch FE and Lasagna L. Adverse drug reactions. A critical review. JAMA 1975; 234: 1236–1241. [https://jamanetwork.com/journals/jama/article-abstract/342706]
20. Weiss FU, et al. ABO blood type B and fucosyltransferase 2 non-secretor status as genetic risk factors for chronic pancreatitis. Gut 2016; 65: 353–354. [https://gut.bmj.com/content/65/2/353.long]
21. Weiss FU, et al. Fucosyltransferase 2 (FUT2) non-secretor status and blood group B are associated with elevated serum lipase activity in asymptomatic subjects, and an increased risk for chronic pancreatitis: a genetic association study. Gut 2015; 64: 646–656.
[https://gut.bmj.com/content/64/4/646.long]
22. Teich N, et al. B lood group B is associated with azathioprine-induced acute pancreatitis in patients with IBD. Gut 2017; 66: 1531–1532. [https://gut.bmj.com/content/66/8/1531.long]
23. Banks PA, et al. Classification of acute pancreatitis--2012: revision of the Atlanta classification and definitions by international consensus. Gut 2013; 62: 102–111. [https://gut.bmj.com/content/62/1/102.long]